ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Is One Immunotherapy for Lung Cancer Better Than the Rest?

Is One Immunotherapy for Lung Cancer Better Than the Rest?

 

In this video, Melissa L. Johnson, MD, of Sarah Cannon Research Institute in Nashville, Tennessee, reviews immunotherapy options now available for the treatment of lung cancer across different lines of therapy and highlights upcoming research in this setting.

Johnson gave a presentation on this topic during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting last month in Chicago.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.